Trasylol Lawsuit
Trasylol (aprotinin) is an injectable medication used to prevent excessive blood loss during heart surgery. A recent national study has found that the drug, which is manufactured by Bayer Pharmaceuticals, may be linked to serious complications including kidney failure and heart problems. The study found the drug increases the risk of heart failure and heart attack by nearly 55%.
The study examined 4,374 heart surgery patients worldwide and found that those on Trasylol were at twice the risk of suffering kidney failure, a heart attack or heart failure. Trasylol was approved in 1993 by the FDA and is commonly used to reduce blood loss and the need for blood transfusion in patients undergoing heart surgery.
Trasylol has been on the market for more than 13 years and is used to prevent bleeding during surgery and to reduce inflammation. A recent study of Trasylol demonstrated side effects including an increased risk of stroke, kidney failure and heart attacks.
It is estimated that the injectable drug may have been given to as many as 1 million patients since its approval by the FDA 13 years ago.
Trasylol Side Effects:
- Difficulty breathing or shortness of breath
- Increased heart rate
- Nausea and vomiting
- Skin irritation and inflammation
- Sudden chest, leg, head, or groin pain
- Swelling of the face, lips, tongue, or neck
If you or a loved one have experienced any side effects from the defective drug Trasylol, please call us at 1.800.966.4999 or fill out our online contact form for a free case evaluation.
